CLOV vs LIN
Clover Health Investments Corp (CLOV) versus Linde plc Ordinary Shares (LIN) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Linde plc Ordinary Shares (LIN) is a specialty chemicals company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported LIN revenue for 2025-12-31 was $33.99B. Net income was $6.90B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
CLOV currently screens at market cap $1.55B. LIN currently screens at market cap $223.87B and trailing P/E 34.5.
Not investment advice. Open the CLOV and LIN stock pages for the full models.
Not investment advice.